Page last updated: 2024-12-07

bis(sulfo-n-succinimidyl)doxyl-2-spiro-4'-pimelate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

bis(sulfo-N-succinimidyl)doxyl-2-spiro-4'-pimelate: structure, RN, & RR from first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID128074
MeSH IDM0142190

Synonyms (7)

Synonym
bssdp
3-oxazolidinyloxy, 2,2-bis(3-((2,5-dioxo-3-sulfo-1-pyrrolidinyl)oxy)-3-oxopropyl)-4,4-dimethyl-
bis(sulfo-n-succinimidyl)doxyl-2-spiro-4'-pimelate
102260-45-7
(2,2-bis{3-[(2,5-dioxo-3-sulfopyrrolidin-1-yl)oxy]-3-oxopropyl}-4,4-dimethyl-1,3-oxazolidin-3-yl)oxidanyl
DTXSID80907306
bis(sulfo-n-succinimidyl)doxyl-2-spiro-4/'-pimelate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]